H.LUNDBECK 20/27 MTNH.LUNDBECK 20/27 MTNH.LUNDBECK 20/27 MTN

H.LUNDBECK 20/27 MTN

No trades
See on Supercharts

Key terms


Outstanding amount
‪500.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
0.88% (Fixed)
Coupon frequency
Annual
Yield to maturity
2.87%
Maturity date
Oct 14, 2027
Term to maturity
2 years

About H.LUNDBECK 20/27 MTN


Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
Issue date
Oct 14, 2020
ISIN
XS2243299463
H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Markets. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

See how H. Lundbeck A/S is moving with its highest-yielding bonds.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.